CAS: 62014-69-1

3β-Isodihydrocadambine is a cadambine derivative that can be extracted from the bark and leaves of Neolamarckia cadamba.

3β-Isodihydrocadambine is a naturally occurring alkaloid, which is extracted from the plant species of the Rubiaceae family, such as Nauclea cadamba. This compound is structurally characterized by specific stereochemistry that contributes to its biological activity. The mode of action primarily involves interaction with various cellular pathways, potentially influencing signaling mechanisms and enzyme activities. Its pharmacological profile has drawn interest due to its potential therapeutic properties, including anti-inflammatory and neuroprotective effects. In research settings, 3β-Isodihydrocadambine is being investigated for its role in modulating immune responses and inhibiting pathological processes that underlie certain diseases. The compound's efficacy in experimental models emphasizes its potential as a lead compound for drug development. Scientists are exploring its applications across a range of biomedical fields, from managing chronic conditions to neurodegenerative diseases, thereby highlighting its significance in the realm of natural product drug discovery.